DUBLIN, Ireland, January 13, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/gxn8lj/bioinformatics) has announced the addition of the "Global Bioinformatics Market 2013 - 2017" report to their offering.
Based on the use of bioinformatics, the various sectors covered in this report are medicine, agriculture, environment, animal, forensic, academics, and others (homeland security and defense, law-enforcement groups, bio-weapon creation, antibiotic resistance, and evolutionary biotechnology). The medical sector accounted for a lions share of the bioinformatics market in 2012. The medical sector has been further classified as molecular medicine, gene therapy, drug discovery and development, clinical diagnostics, and reproductive biotechnology.
The bioinformatics market, by products and services, has been classified as knowledge management tools, platforms, and services. These segments are integral components of application areas such genomics, proteomics, and other life-science research, and are used for the acquisition, development, management, analysis, and integration of huge amounts of data generated during biological research. Knowledge management tools dominated the bioinformatics market in 2012, followed by platforms and services. Knowledge management tools are majorly used by researchers to handle large volumes of heterogeneous information and to integrate them with existing knowledge repositories.
Segments in the bioinformatics application market are genomics, proteomics, chemoinformatics, molecular phylogenetics, metabolomics, transcriptomics, and others (glycomics, cytomics, physiomics and interactomics). Genomics contributes the highest to the bioinformatics market; it is poised to grow at a high CAGR from 2012 to 2017. The application of bioinformatics in genomics is driven by growing pharmacogenomics applications for the discovery of new drugs and characterization of older drugs, development of new bioinformatics tools to handle large sets of data generated through genomics research, and decreasing cost of DNA sequencing. Metabolomics is the fastest-growing application area due to developments in analytical instruments that enable profiling of metabolites with high throughput and accuracy.
North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2012. This is attributed by an increasing demand for bioinformatics in genomics and proteomics research, technological advancements, growing use of bioinformatics tools in the drug discovery process, and presence of a large number of market players. However, other regions such as Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of Contract Research Organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships.
Major players in the bioinformatics industry include Accelrys, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC bio. (Denmark).
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Bioinformatics Market, By Sectors
5 Global Bioinformatics Market, By Products & Services
6 Global Bioinformatics Market, By Applications
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
- Accelrys, Inc
- Active Motif, Inc
- Affymetrix, Inc
- Agilent Technologies, Inc
- Biomatters, Ltd
- Biomax Informatics Ag
- Clc Bio
- Geneva Bioinfromatics (Genebio) Sa
- Id Business Solutions Ltd
- Illumina, Inc
- Instem Plc
- Integromics SL
- Kinexus Bioinformatics Corporation
- Knome, Inc
- Life Technologies Corporation
- Nonlinear Dynamics Ltd
- Ocimum Biosolutions, Ltd
- Partek, Incorporated
- Perkinelmer, Inc
- Textco Biosoftware, Inc
For more information visit http://www.researchandmarkets.com/research/gxn8lj/bioinformatics
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets